Baird Medical Investment Holdings Limited
BDMD · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | $7,959 | $23,901 | $13,137 | $19,912 |
| % Growth | -66.7% | 81.9% | -34% | – |
| Cost of Goods Sold | $1,424 | $2,738 | $1,646 | $2,184 |
| Gross Profit | $6,535 | $21,163 | $11,491 | $17,727 |
| % Margin | 82.1% | 88.5% | 87.5% | 89% |
| R&D Expenses | $7,180 | $4,147 | $2,027 | $1,988 |
| G&A Expenses | $0 | $4,097 | $3,006 | $6,173 |
| SG&A Expenses | $9,805 | $6,790 | $4,374 | $6,871 |
| Sales & Mktg Exp. | $0 | $2,893 | $1,169 | $898 |
| Other Operating Expenses | $0 | $0 | -$0 | -$0 |
| Operating Expenses | $16,986 | $10,937 | $6,402 | $8,859 |
| Operating Income | -$10,450 | $10,226 | $5,089 | $8,868 |
| % Margin | -131.3% | 42.8% | 38.7% | 44.5% |
| Other Income/Exp. Net | -$350 | -$995 | -$233 | $554 |
| Pre-Tax Income | -$10,800 | $9,231 | $4,856 | $9,422 |
| Tax Expense | $559 | $1,008 | $481 | $1,119 |
| Net Income | -$11,294 | $8,123 | $4,330 | $8,216 |
| % Margin | -141.9% | 34% | 33% | 41.3% |
| EPS | -0.43 | 0.38 | -0.318 | 0.38 |
| % Growth | -213.2% | 219.5% | -183.7% | – |
| EPS Diluted | -0.43 | 0.38 | -0.318 | 0.38 |
| Weighted Avg Shares Out | 26,402 | 21,699 | 7,471 | 5,152 |
| Weighted Avg Shares Out Dil | 26,402 | 21,844 | 7,471 | 5,152 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $0 | $0 | $0 |
| Interest Expense | $358 | $338 | $239 | $202 |
| Depreciation & Amortization | $790 | $546 | $593 | $602 |
| EBITDA | -$9,652 | $10,772 | $5,682 | $9,470 |
| % Margin | -121.3% | 45.1% | 43.3% | 47.6% |